---
title: "3种EMT打分算法"
date: 2023-09-22T16:14:05Z
draft: ["false"]
tags: [
  "fetched",
  "生信技能树"
]
categories: ["Acdemic"]
---
3种EMT打分算法 by 生信技能树
------
<div><section data-tool="mdnice编辑器" data-website="https://www.mdnice.com"><blockquote data-tool="mdnice编辑器"><p>看到一个预印本文章对3种EMT打分算法进行了测评，挺有意思的，标题是：《Comparative study of transcriptomics-based scoring metrics for the epithelial-hybrid-mesenchymal spectrum》，链接在 https://www.biorxiv.org/content/10.1101/2020.01.02.892604v1.full</p></blockquote><p data-tool="mdnice编辑器">这3种方法的示意图如下所示：</p><p><img data-ratio="0.64375" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/cZNhZQ6j4wz2A812vBjgeAgZYpFNgyXjZEWS57Qc8wgGpbakuPc7YbqtPiaib2Jx439lNw4A7u4xwdZ1rxg7icpEQ/640?wx_fmt=png" data-type="png" data-w="1280" src="https://mmbiz.qpic.cn/mmbiz_png/cZNhZQ6j4wz2A812vBjgeAgZYpFNgyXjZEWS57Qc8wgGpbakuPc7YbqtPiaib2Jx439lNw4A7u4xwdZ1rxg7icpEQ/640?wx_fmt=png"></p><figure data-tool="mdnice编辑器"><figcaption> </figcaption></figure><h3 data-tool="mdnice编辑器"><span></span>加权线性加和（76-gene EMT signature）<span></span></h3><p data-tool="mdnice编辑器">这个算法对CDH1 (E-cadherin)的权重很高，所以epithelial的EMT scores是比mesenchymal高。</p><p data-tool="mdnice编辑器">参考文献：An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clin. Cancer Res.</p><h3 data-tool="mdnice编辑器"><span></span>two-sample Kolmogorov-Smirnov test<span></span></h3><p data-tool="mdnice编辑器">This score varies on a scale of −1 to 1, with the higher scores corresponding to more mesenchymal samples (Tan et al., 2014).</p><p data-tool="mdnice编辑器">参考文献：Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients. EMBO Mol. Med.</p><h3 data-tool="mdnice编辑器"><span></span>multinomial logistic regression<span></span></h3><p data-tool="mdnice编辑器">它的值集中于0到2之间， This method particularly focuses on characterizing a hybrid E/M phenotype using the expression levels of 23 genes – 3 predictors and 20 normalizers – identified through NCI-60 gene expression data.</p><p data-tool="mdnice编辑器">会把样品判断为3种状态：epithelial, mesenchymal, or hybrid E/M categories</p><p data-tool="mdnice编辑器">参考文献是：2017). Survival outcomes in cancer patients predicted by a partial EMT gene expression scoring metric. Cancer Res. <strong>77</strong>, 6415–6428. doi:10.1158/0008-5472.CAN-16-3521.</p><h3 data-tool="mdnice编辑器"><span></span>为什么没有gsva的打分呢？<span></span></h3><ul data-tool="mdnice编辑器"><li><section>GSVA生存分析教学视频 https://www.bilibili.com/video/av81874183</section></li><li><section>https://mp.weixin.qq.com/s/LJjsdf3X66nJ1KmpvvkHOA</section></li></ul><h3 data-tool="mdnice编辑器"><span></span>每个文章都有自己的EMT打分算法<span></span></h3><p data-tool="mdnice编辑器">比如发表于2020年1月的文章；《Gene signatures of tumor inflammation and epithelial-to-mesenchymal transition (EMT) predict responses to immune checkpoint blockade in lung cancer with high accuracy》，链接是：https://www.sciencedirect.com/science/article/pii/S0169500219306932</p><ul data-tool="mdnice编辑器"><li><section>There is not yet a validated lung cancer EMT signature, so we prospectively generated a gene list based on previous publications describing “classic” EMT genes in cancer [23,24] with the addition of some genes specifically mentioned in studies evaluating EMT in NSCLC [27–29].</section></li><li><section>Selected genes had levels of expression that were clearly above baseline (using a cutoff of 10 reads in our data set). Supplemental Table 2 shows the list of genes included along with their average expression level.</section></li><li><section>Although the genes SNAI1, TWIST1, TWIST2, CDH2, and ZEB1 are classic mesenchymal markers, their expression levels were very low in our dataset and thus not included.</section></li><li><section>Based on these criteria, we generated the EMT signature by adding the sum of the log2 Z scores of 6 established mesenchymal genes (AGER, FN1, MMP2, SNAI2, VIM, ZEB2) and subtracting the sum of the log2 Z scores of 6 established epithelial genes (CDH1, CDH3, CLDN4, EPCAM, MAL2, and ST14) (Supplemental Table 2).</section></li><li><section>In this signature, the most mesenchymal tumors have the most positive EMT scores and the most epithelial tumors have the most negative scores.</section></li></ul><p data-tool="mdnice编辑器">总结起来，其实超级简单，就是选取高表达量的EMT基因，然后6个mesenchymal基因 的log2 Z scores 值的和，减去6个epithelial 基因 的log2 Z scores 值的和，所以这个EMT 打分越高就说明它是mesenchymal 的。</p><h3 data-tool="mdnice编辑器"><span></span>EMT 背景知识<span></span></h3><blockquote data-tool="mdnice编辑器"><p><strong>EMT，全称epithelial–mesenchymal transition，又称翻译为上皮间质转换，指的是上皮细胞在一些因素的作用下,失去极性及细胞间紧密连接和黏附连接, 获得了浸润性和游走迁移能力, 变成具备间质细胞形态和特性的细胞的改变。这种行为是可逆的。</strong></p></blockquote><p data-tool="mdnice编辑器">EMT的概念最早是1982年由Green-berg和Hay提出。然而，长久以来，科学界对于EMT在肿瘤转移过程中的作用一直存在争议，<strong>主要是因为无法在体内观察EMT过程 。</strong></p><p data-tool="mdnice编辑器">胚胎发育与癌症发展中的细胞可塑性变化有着惊人的相似性，**而这种可塑性变化受到上皮间质转化epithelial-mesenchymal transition （EMT）过程的调节。**胚胎发育时期，上皮状态和间充质状态的细胞能够自由转化。</p><ul data-tool="mdnice编辑器"><li><section>上皮间质转化（EMT）<strong>使得细胞具备转移和浸润特性。</strong></section></li><li><section>其反向过程，间质上皮转化mesenchymal-epithelialtransition （MET）赋予了细胞极性变化并失去移动能力。</section></li></ul><p data-tool="mdnice编辑器">EMT会促发癌细胞从病灶分离，转移到其它部位，而MET导致癌细胞停留，并在停留处引起新的肿瘤。</p><p data-tool="mdnice编辑器">在很长一段时间内，<strong>许多科学家都认为EMT过程对于肿瘤转移是一个必须条件</strong>，EMT过程能够剥夺细胞与邻近细胞紧密结合的能力，使细胞能够在全身范围内迁移。科学家们认为是EMT给了癌细胞“双腿”让它们能够脱离原位肿瘤，转移到其他部位形成肿瘤转移灶。</p><p data-tool="mdnice编辑器"><strong>一、 首先介绍下，EMT发生常见的标志分子。</strong></p><p data-tool="mdnice编辑器">1.表达减少：E- cadherin，Cytokeratin，ZO-1。</p><p data-tool="mdnice编辑器">2.表达增多：N- cadherin，Vinmentin，Snail1，Snail2，Twi  st，MMP-2，MMP-3，MMP-9。</p><p data-tool="mdnice编辑器">3.活性增加：ILK，Rho。</p><p data-tool="mdnice编辑器"><strong>二．参与EMT过程控制的常见信号通路有：</strong></p><p data-tool="mdnice编辑器">1.TGF-β信号通路。</p><p data-tool="mdnice编辑器">2.Wnt信号通路。</p><p data-tool="mdnice编辑器">3.Notch信号通路。</p><p data-tool="mdnice编辑器">4.SMAD信号通路。</p><p data-tool="mdnice编辑器">5.PI3K-AKT-MTOR信号通路。</p><p data-tool="mdnice编辑器"><strong>三. EMT过程有着复杂的调节网络：</strong></p><p data-tool="mdnice编辑器">表观遗传的调节</p><p data-tool="mdnice编辑器">转录调节</p><p data-tool="mdnice编辑器">选择性剪接</p><p data-tool="mdnice编辑器">蛋白质的稳定</p><p data-tool="mdnice编辑器">亚细胞定位</p><p data-tool="mdnice编辑器">这些调节方式多样性使得EMT的调节往往不是线性的。此前，EMT调节过程中关于E-cadherin的转录，EMT转录因子SNAI1，SNAI2， ZEB1，ZEB1和 TWIST1等研究较多。</p><h3 data-tool="mdnice编辑器"><span></span>上皮细胞黏附分子（EpCAM）<span></span></h3><p data-tool="mdnice编辑器">与普通血细胞相比,CTCs具有某些特殊的生物标志物,包括CTCs表面的上皮细胞粘附分子(Epithelial cell adhesion molecule,EpCAM)</p><p data-tool="mdnice编辑器">不同文献报道不一致：</p><ul data-tool="mdnice编辑器"><li><section>在咽癌中Ep-CAM高表达与淋巴结转移密切相关，Ep-CAM表达越高，淋巴结转移发生频率越高</section></li><li><section>在头颈部鳞状细胞癌中，Ep-CAM在转移灶中表达比原发灶更高</section></li><li><section>在胃癌骨髓转移灶中的播散性肿瘤细胞Ep-CAM的表达较原发灶降低</section></li></ul><p data-tool="mdnice编辑器">免疫组织化学中的细胞角蛋白(Cytokeratin, CK) :</p><h3 data-tool="mdnice编辑器"><span></span>EMT基因集<span></span></h3><p data-tool="mdnice编辑器">简单搜索了一下， 确实是热点：</p><ul data-tool="mdnice编辑器"><li><section>早在2010的PANS文章https://doi.org/10.1073/pnas.1004900107 就定义过 EMT Core Signature 基因集合We identified an EMT core signature consisting of 159 genes that were down-regulated and 87 genes that were up-regulated at least 2-fold by all of these EMT-inducing signals (Table S1). 数据在 GSE9691 和 GSE9691</section></li><li><section>然后是 2012 的 Meta-Analysis of Gene Expression  https://doi.org/10.1371/journal.pone.0051136 也发布了基因集，包括 EMT-core gene list of 130 up- or downregulated genes shared between at least 10 GES datasets.和 List of 365 genes significantly regulated in at least 10 GES datasets.</section></li><li><section>也可以在 Pan‐cancer genomic datasets from The Cancer Genome Atlas (TCGA), representing over 10,000 patients and 32 distinct cancer types, provide a rich resource for examining correlative patterns involving EMT mediators in the setting of human cancers.验证：https://onlinelibrary.wiley.com/doi/pdf/10.1002/dvdy.24485</section></li><li><section>2015 数据库 dbEMT   但是引用率不高， - ‎被引用次数：28  其整理的 All the 377 human Epithelial-Mesenchymal Transition genes with cancer types 数据是可以下载的：http://dbemt.bioinfo-minzhao.org/download.cgi</section></li><li><section>最后是 2020的这个最新了，The web-based EMTome portal is a resource for primary and metastatic tumour research publicly available at www.emtome.org. 文章链接是：https://www.nature.com/articles/s41416-020-01178-9</section></li></ul></section></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/hYfXZ0iBCUrHIwVvWv-a1A",target="_blank" rel="noopener noreferrer">原文链接</a>
